Brokers Recommendations on: Tandem Diabetes Care inc (NASDAQ:TNDM)


Tandem Diabetes Care inc (NASDAQ:TNDM) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Tandem Diabetes Care inc (NASDAQ:TNDM) gained 4.65 Percent and closed its previous trading session at $25.45. The stock traded with the average Volume of 2.48 Million at the end of last session.

Tandem Diabetes Care inc (NASDAQ:TNDM) has the Market Capitalization of 1.22 Billion. The Stock has its 52-week High of $26.24 and 52-Week Low of $ 2.14 and it touched its 52-week high on 07/12/18 and 52-Week Low on 02/09/18


The company reported its last earnings Actual EPS of $-1.82/share. While, the analyst predicted that the company could provide an EPS of $-0.59/share. Hence the difference between Predicted EPS and Actual EPS reported is $-1.23/share which shows an Earnings Surprise of -208.5 Percent.

Sell side analysts plays vital role in buying and selling a stock where 1 analysts rated Tandem Diabetes Care inc (NASDAQ:TNDM) as Buy, 0 analysts given Outperform signal, 1 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 17.33% where SMA50 and SMA200 are 58.36% and 270.04% respectively.

The company shows its Return on Assets (ROA) value of -76.8%. The Return on Equity (ROE) value stands at 515.8%. While it’s Return on Investment (ROI) value is -241.7%.

Tandem Diabetes Care inc (NASDAQ:TNDM) currently has a Weekly Volatility of 6.23% percent while its Monthly Volatility is at 9.30% percent. While talking about Performance of the Stock, Tandem Diabetes Care inc currently has a Weekly performance of 9.98%, monthly performance percentage is 43.79 percent, Quarterly performance is 268.31 percent, 6 months performance shows a percent value of 641.98% and Yearly Performance is 338.04 percent.

Company Profile:

Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.